Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page
- Check2 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3. This reflects a small backend or UI update that does not affect the study details or data presented on the page.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the prior v3.6.0. This indicates an updated build/version of the site's content without altering visible study details.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedNew navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions label was standardized to 'Intervention/Treatment' while removing the older 'Intervention / Treatment' phrasing. The page now indicates 'No longer looking for participants' for closed enrollment and the revision note was updated to v3.6.0, replacing v3.5.5.SummaryDifference0.4%

- Check31 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the study page, signaling a platform/content rendering update to the record. This does not modify study details or outcomes.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a new release of the page. The change represents a revision of the page version rather than modifications to the study data.SummaryDifference0.1%

- Check60 days agoChange DetectedA new publication citation by Fountzilas et al. is added to the study's publications with full bibliographic details, replacing the previous online-ahead-of-print entry.SummaryDifference0.1%

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.